S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators

British Journal of Pharmacology
P J HenryJ D Horowitz

Abstract

1. The formation of an S-nitrosothiol compound, S-nitroso-N-acetylcysteine (SNAC) has recently been proposed to mediate the augmentation of the anti-aggregatory and haemodynamic effects of glyceryl trinitrate observed in the presence of N-acetylcysteine. This study investigated the effects on an isolated coronary artery preparation of acute and prolonged exposure to S-nitrosothiol compounds and nitric oxide (NO). 2. Single doses of NO and of the S-nitrosothiol compounds, SNAC and S-nitroso-N-acetyl-penicillamine (SNAP), induced rapid, but transient, relaxations in U46619-contracted bovine isolated coronary artery rings. Peak relaxation responses to SNAP and NO were attenuated in the presence of N-acetylcysteine, cysteine, ascorbic acid and methylene blue. The duration of the relaxation responses to SNAC was two to three times longer than those to SNAP and NO. In the presence of N-acetylcysteine (but not cysteine, ascorbic acid or methylene blue) the duration of the relaxation responses to SNAP and NO (but not to SNAC) was markedly increased. H.p.l.c. assay confirmed that, in the presence of N-acetylcysteine, SNAP and, to a lesser degree, NO were converted to the relatively more stable and longer acting vasodilator, SNAC. 3. Whe...Continue Reading

References

Aug 1, 1985·The Journal of Clinical Investigation·J Loscalzo
Jan 19, 1987·The Medical Journal of Australia·J D Horowitz, P J Henry
Sep 24, 1987·The New England Journal of Medicine·M PackerM Yushak
Sep 24, 1987·The New England Journal of Medicine·D C MayL D Hillis
Dec 15, 1987·European Journal of Pharmacology·E A KowalukH L Fung
Sep 1, 1988·The American Journal of Cardiology·J StamlerJ Loscalzo
Feb 1, 1988·Clinical and Experimental Pharmacology & Physiology·G J DustingA G Stewart
Jun 11, 1987·Nature·P M Vanhoutte
Nov 1, 1987·British Journal of Pharmacology·K ShikanoB A Berkowitz
Dec 1, 1986·Circulation·J Abrams
Jan 1, 1984·Annual Review of Pharmacology and Toxicology·R F Furchgott
Jul 1, 1980·Circulation Research·S WallensteinJ L Fleiss

❮ Previous
Next ❯

Citations

Dec 3, 2011·Cardiovascular Drugs and Therapy·Francesco Iachini BellisariiRaffaele De Caterina
Oct 29, 1990·Brain Research·S T MellerG F Gebhart
Jun 18, 1991·European Journal of Pharmacology·P J SilverR A Buchholz
Feb 11, 1994·European Journal of Pharmacology·C L ZhangJ D Horowitz
Mar 1, 1995·Comparative Biochemistry and Physiology. Part A, Physiology·S C Langley-Evans, A A Jackson
Dec 27, 1996·European Journal of Pharmacology·I S De la LandeJ D Horowitz
May 26, 1998·European Journal of Pharmacology·A PapapetropoulosJ D Catravas
Dec 16, 1998·European Journal of Pharmacology·C GöçmenF Baysal
Jun 12, 2003·Journal of the American College of Cardiology·John D Horowitz
Aug 6, 2000·Free Radical Biology & Medicine·N Hogg
Aug 15, 2002·Nitric Oxide : Biology and Chemistry·Kelly Fabiane Santos RicardoMarta Helena Krieger
May 25, 2002·British Journal of Pharmacology·J W WegenerH Nawrath
Dec 1, 1994·British Journal of Clinical Pharmacology·G W HeA Starr
Jan 1, 1992·British Journal of Pharmacology·J C Wanstall, S R O'Donnell
Apr 1, 1994·British Journal of Pharmacology·A J Barbier, R A Lefebvre
Jan 1, 1996·British Journal of Pharmacology·A PapapetropoulosJ D Catravas
Feb 9, 2016·Journal of Pharmaceutical Sciences·Gabriela Freitas Pereira de Souza, Marcelo Ganzarolli de Oliveira
Jun 19, 2012·Nitric Oxide : Biology and Chemistry·Parimala NacharajuJoel M Friedman
Jan 18, 2005·The Journal of Surgical Research·Paul SorajjaHartzell V Schaff
Apr 24, 1999·The Annals of Thoracic Surgery·F L RosenfeldtJ A Angus
Dec 3, 2014·Nanomedicine : Nanotechnology, Biology, and Medicine·Breanne MordorskiAdam J Friedman
Dec 3, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Wen WuAnne Sapin-Minet
Sep 28, 2002·Journal of Cardiovascular Pharmacology·Andrey V GourinePer-Ove Sjöquist
Jan 1, 1996·Vascular Medicine·G R UpchurchJ Loscalzo
Jun 26, 1999·British Journal of Clinical Pharmacology·G W He, C Q Yang
Mar 1, 1995·Cancer Treatment Reviews·S M SagarA C Whitton
Aug 1, 1992·Analytical Biochemistry·R M Clancy, S B Abramson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.